Business
Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?
Image source: Getty Images
When a company sheds over $100 billion of market value in one day, you sit up and pay attention, especially when that company is one of the largest companies in Europe.
Novo Nordisk (NYSE: NVO), the Danish pharmaceutical giant that launched the semaglutide sold under…
Continue Reading
-
General20 hours agoLogies 2025 winners list: Lynne McGranger wins gold, Fisk sweeps comedy categories
-
General7 hours agoBali scooter crash victim Keanu Neilsen’s surgery could cost more than $100,000
-
Business13 hours agoCan you guess which 2 Big 4 banks Macquarie prefers?
-
General23 hours agoThe forgotten terms of good and evil